Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
Status:
Completed
Trial end date:
2020-08-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administrated
Rosuvastatin/Ezetimibe and Telmisartan in patients with primary hypercholesterolemia and
essential hypertension.